Advances in the approaches used to repurpose drugs for neuroblastoma

Author:

Miera-Maluenda Marta1,Pérez-Torres María2,Mañas Adriana34ORCID,Rubio-San-Simón Alba5,Butjosa-Espín Maria6,Ruiz-Duran Paula1,Seoane Jose A.6,Moreno Lucas12ORCID,Segura Miguel F.1ORCID

Affiliation:

1. Childhood Cancer and Blood Disorders Group, Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain

2. Department of Pediatric Oncology and Hematology, Vall D’Hebron University Hospital, Barcelona, Spain

3. Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain

4. IdiPAZ-CNIO Pediatric Onco-Hematology Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

5. Pediatric Oncology and Hematology Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain

6. Cancer Computational Biology Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Funder

Instituto de Salud Carlos III

European Regional Development Fund

European Social Fund

Fundación Neuroblastoma and Neuroblastoma por Leire

Publisher

Informa UK Limited

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3